After a first experience within Pfizer Oncology French Medical Affairs department, I moved to Marketing joining the European Pfizer Oncology Brand Team in 2007.
I've participated in launch Sutent in multiple indications during 3 years accross Europe.
Then I moved in June 2010 to a new Marketing role, to focus on a specific asset of Pfizer Oncology pipeline. This allowed me to work on pre-launch and launch of axitinib, approved by EMA in 2012 in RCC.
Since april 2013, I've moved to the Ipsen Global Uro-Oncology team and I'm now dedicated to the pre-launch of an innovative product currently in phase III, aiming to improves patients outcomes in mCRPC.
Mes compétences :
Oncologie
Industrie pharmaceutique
Marketing
Pharmacie
Gestion de projet
Communication
Management